Page 113 - MEMOCibersam014

(BDNF) levels . Psychological Medicine, 44(11): 2409-2418 . 2014 . F .I .: 5,4280 .
110 . Yildiz A ., Nikodem M ., Vieta E ., Correll C .U ., Baldessarini R .J . A network meta-analysis on com- parative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania . Psychological Medicine, 2014 . [Epub ahead of print] . F .I .: 5,4280 .
111 . Arango C . Present and future of developmental neuropsychopharmacology . European neurop- sychopharmacology : the journal of the European College of Neuropsychopharmacology, 2014 . [Epub ahead of print] . F .I: 5,3950 .
112 . Bravo L ., Torres-Sanchez S ., Alba-Delgado C ., Mico J .A ., Berrocoso E . Pain exacerbates chronic mild stress-induced changes in noradrenergic transmission in rats . European Neuropsychophar- macology, 24(6): 996-1003 . 2014 . F .I .: 5,3950 .
113 . Fonseca F., Gratacos M., Escaramis G., De Cid R., Martin-Santos R., Farre M., Estivill X., Torrens M . ALDH5A1 variability in opioid dependent patients could influence response to methadone treatment . European Neuropsychopharmacology, 24(3): 420-424 . 2014 . F .I .: 5,3950 .
114 . Forcada I ., Mur M ., Mora E ., Vieta E ., Bartres-Faz D ., Portella M .J . The influence of cognitive re- serve on psychosocial and neuropsychological functioning in bipolar disorder . European Neurop- sychopharmacology, 2014 . [Epub ahead of print] . F .I .: 5,3950 .
115 . Gimenez M ., Ortiz H ., Soriano-Mas C ., Lopez-Sola M ., Farre M ., Deus J ., Martin-Santos R ., Fernan- des S ., Fina P ., Bani M ., Zancan S ., Pujol J ., Merlo-Pich E . Functional effects of chronic paroxetine versus placebo on the fear, stress and anxiety brain circuit in Social Anxiety Disorder: Initial vali- dation of an imaging protocol for drug discovery . European Neuropsychopharmacology, 24(1): 105-116 . 2014 . F .I .: 5,3950 .
116 . Gomez-Sintes R ., Bortolozzi A ., Artigas F ., Lucas J .J . Reduced striatal dopamine DA D2 recep- tor function in dominant-negative GSK-3 transgenic mice . European Neuropsychopharmacology, 24(9): 1524-1533 . 2014 . F .I .: 5,3950 .
117 . Huerta-Ramos E ., Iniesta R ., Ochoa S ., Cobo J ., Miquel E ., Roca M ., Serrano-Blanco A ., Teba F ., Usall J . Effects of raloxifene on cognition in postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial . European Neuropsychopharmacology, 24(2): 223-231 . 2014 . F .I .: 5,3950 .
118 . Jimenez E ., Arias B ., Mitjans M ., Goikolea J .M ., Roda E ., Ruiz V ., Perez A ., Saiz P .A ., Paz Garcia- Portilla M., Buron P., Bobes J., Vieta E., Benabarre A. Association between GSK3β gene and increased impulsivity in bipolar disorder . European Neuropsychopharmacology, 24(4): 510-518 . 2014 . F .I .: 5,3950 .
119 . Lara E ., Olaya B ., Garin N ., Ayuso-Mateos J .L ., Miret M ., Moneta V ., Haro J .M . Is cognitive impair- ment associated with suicidality? A population-based study . European Neuropsychopharmacolo- gy, 2014 . [Epub ahead of print] . F .I .: 5,3950 .
120 . Lara E ., Olaya B ., Garin N ., Ayuso-Mateos J .L ., Miret M ., Moneta V ., Haro J .M . Is cognitive impair- ment associated with suicidality? A population-based study . European Neuropsychopharmacolo- gy, 2014 . [Epub ahead of print] . F .I .: 5,3950 .
121 . Mercedes Perez-Rodriguez M ., Mahon K ., Russo M ., Ungar A .K ., Burdick K .E . Oxytocin and social cognition in affective and psychotic disorders . European Neuropsychopharmacology, 2014 . [Epub ahead of print] . F .I .: 5,3950 .
122 . Schumann G ., Binder E .B ., Holte A ., de Kloet E .R ., Oedegaard K .J ., Robbins T .W ., Walker-Tilley T .R ., Bitter I ., Brown V .J ., Buitelaar J ., Ciccocioppo R ., Cools R ., Escera C ., Fleischhacker W ., Flor H ., Frith C .D ., Heinz A ., Johnsen E ., Kirschbaum C ., Klin . Stratified medicine for mental disorders . European Neuropsychopharmacology, 24(1): 5-50 . 2014 . F .I .: 5,3950 .
www.cibersam.es 113